Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX1106 in advanced head and neck squamous cell carcinoma
NCT04093115Phase 2Withdrawn
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of CX1106 in head and neck squamous cell carcinoma (HNSCC), sponsored by Beijing Konruns Pharmaceutical Co., Ltd.. Planned start Dec 2019; status: withdrawn.
02
Drugs
CX1106
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04093115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04093115.